Lungs Europe is responsible for communication and stakeholder engagement. Along with other partners, Lungs Europe will follow a joint strategy to create awareness among the widest possible audience concerning EU PAL-COPD activities, results and outcomes. Lungs Europe brings together all key stakeholders within respiratory health. It is s partnership between the European Lung Foundation (ELF) and the European Respiratory Society (ERS). 

In EU PAL-COPD, ELF will ensure patient involvement, and it will guarantee that patient expectations, needs and requirements are fulfilled and taken up within WP2. ELF’s Patient Advisory Group will give input and feedback on patient expectations and requirements in advance of the trial being implemented in the different partner countries. It will also organise virtual patient conferences.

ERS is the WP9 co-leader. It will organise online focus groups to investigate clinicians acceptability of the stepped wedge design. It will also launch online surveys, together with EAPC.

EU PAL-COPD is funded by the European Union (grant no. 101136621). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

This project is also supported by Innovate UK, the Swiss State Secretariat for Education, Research and Innovation (SERI), and the Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Fund.